IDWeek 2024

IDWeek 2024

Holder H, et al.

Patient Experiences at Month 6 after Initiation of Cabotegravir Long-Acting (CAB LA) for PrEP in the First Male Gender Concordant Implementation Science Trial (PILLAR) in the US

IDWeek24_P16_1424_2024-10-15
Video Player is loading.
Current Time 0:00
Duration 4:26
Loaded: 2.23%
Stream Type LIVE
Remaining Time 4:26
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected
    Navigate to: